Structural racism and limited resources can pose barriers to type 2 diabetes care in Black patients. A Black physician and ...
Women with diabetes are at a higher risk of heart disease due to various factors such as hormonal imbalance and atypical ...
Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...
Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among ...
Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.
Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...
If you have diabetes, there are many factors at play when you choose the time for eating your breakfast. For those with high ...
Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...
50m
India Today on MSNMankind Pharma launches generic for popular diabetes drug at one-tenth the costMankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...
Discover simple lifestyle changes backed by research that can significantly lower your type 2 diabetes risk without requiring ...
New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...
Glenmark launches Empagliflozin and combinations in India under Glempa brand, aiming to improve glycemic control and reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results